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1 Authors equally contribute to the work.Among the different mechanisms underlying the etiopathogenesis of myotonic dystrophy type 1
(DM1), a backward reprogramming to a foetal splicing machinery is an interesting hypothesis. To
address this possibility, Tau splicing, which is regulated during development and modiﬁed in
DM1, was analyzed. Indeed, a preferential expression of the foetal Tau isoform, instead of the six
normally found, is observed in adult DM1 brains. By using two cell lines, we show here that the
cis-regulating elements necessary to generate the unique foetal Tau isoform are dispensable to
reproduce the trans-dominant effect induced by DM1 mutation on Tau exon 2 inclusion. Our results
suggest that the mis-splicing of Tau in DM1 is resulting from a disease-associated mechanism.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction scripts is altered in several organs (heart, skeletal muscle, brain,Myotonic dystrophy of type 1 (DM1) is a multisystemic disorder
characterized by myotonia, progressive muscle weakness, wasting
of skeletal muscle and extramuscular symptoms including brain
dysfunctions (for review see [1,2]). Neurological symptoms include
mental retardation, sleep disorders, behavioural changes, altera-
tions in brain structure and cognitive deﬁcits (for review see [3,4]).
DM1 is caused by a pathological expansion of an unstable CTG
repeat (n > 50) located in the 30 untranslated region of myotonic
dystrophy protein kinase gene (DMPK) [5]. Clinical expression of
DM1 is likely the consequence of a pathogenic RNA gain of function
mechanism by which the CUG repeats alter the function of splicing
factors such as MBNL and CELF families [6]. As a consequence,
alternative splicing of cardiac Troponin T (hcTNT), Insulin Receptor
(IR), Tau and muscle-speciﬁc Chloride Channel-1 (ClC-1) tran-chemical Societies. Published by E
dystrophia myotonia protein
nel-1; IR, insulin receptor
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ergeant), marie-laure.caillet-
M.-L. Caillet-Boudi).etc.) (for review see [7]). The modiﬁed splicing of these transcripts
is paralleled by the clinical symptoms.
Noteworthy, the splicing defect consists of the preferential
expression of the foetal isoforms of numerous transcripts targeted
by the trans effect of the mutation (reviewed in [7]). This observa-
tion could suggest that CUG repeats induce an adult to foetal repro-
gramming of the splicing machinery in DM1. Alternatively, the
DM1 foetal-type pattern could result from a disease-associated
mechanism. In the brain and muscles of DM1 patients, we and oth-
ers reported a modiﬁed splicing of Tau that clearly favourites the
expression of the unique foetal human brain isoform [8–11]. In
adult human central nervous system, six major isoforms of Tau
are expressed that differ from each other by the inclusion or exclu-
sion of exons 2, 3 and 10 (For review see [12]). In the human foetal
brain, one Tau isoform lacking exons 2, 3 and 10 is expressed. Thus,
as described for other transcripts such as hcTNT and IR, the DM1
altered splicing leads to an increased expression of the unique foe-
tal isoform of Tau.
In the present study, we evaluated whether the splicing mech-
anism leading to a foetal-type splicing of Tau results from an adult
to foetal reprogramming of the splicing machinery or from DM1
speciﬁc mechanism. Because Tau exon 2 is largely included in
human adult brain and preferentially excluded in DM1 brain, we
focused our study on exon 2 splicing mechanism. We compared the
splicing effect of CTG repeats on exon 2 splicing from endogenouslsevier B.V. All rights reserved.
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Fig. 1. Alternative splicing of endogenous Tau in human Glioblastoma T98 and
Neuroblastoma SY5Y cell lines. Splicing proﬁle is analyzed by RT-PCR using Tau E1/
E13 primer pair in (A), Tau E1/E4 primer pair in (B) and Tau E9/E13 (C) (see Table 1
for the localization of Tau primers). 18S ampliﬁcation is used as control of the RNA
quantity ampliﬁed in (D). Note the preferential inclusion of exon 2 of Tau in T98 cell
line and its preferential exclusion in SY5Y cell line. The quantitative analysis of Tau
isoform expression is represented in (E). Signiﬁcant differences in the isoforms
expression between the two cell lines are indicated by asterisks (*, P < 0.05; **,
P < 0.01).
676 D. Ghanem et al. / FEBS Letters 583 (2009) 675–679or minigene tau transcripts in two human cell lines characterized
by a different Tau splicing pattern.
2. Materials and methods
2.1. Cell culture and transfection
Human glioblastoma T98G (T98) and neuroblastoma SK-N-SH
SY5Y (SY5Y) cell lines were maintained in DMEM medium supple-
mented with 10% foetal calf serum, 50 IU/ml penicillin, 50 lg/mlTable 1
List of primers used to analyze the expression of Tau isoforms and the alternative splicing
(Exon: E). The second contains the sequence of the forward and reverse primers (Sense/Anti
Sequence ampliﬁed Sense/antisense primers PCR c
Tau E1 > E13 50-GTTGGGGGACAGGAAAGATC-30 65 C
50-GTCTACCATGTCGATGCTGC-30
Tau E1 > E4 50-TACGGGTTGGGGGACAGGAAAGAT-30 65 C
50-GGGGTGTCTCCAATGCCTGCTTCT-30
Tau exon 2/3, Ins1 > Ins3 50-CAGCTACAGTCGGAAACCATCAGCAAGCA-30 65 C
50-CACCTCCAGTGCCAAGGTCTGAAGGTCACC-30
Tau exon 2D3, Ins1 > Ins3 50-CAGCTACAGTCGGAAACCATCAGCAAGCA-30 65 C
50-CACCTCCAGTGCCAAGGTCTGAAGGTCACC-30
TauE9 > E13 50-CATGGCAGACCTGAAGAATGTCAAG-30 65 C
50-TCACAAACCCTGCTTGGCCA-30
ARN18S 50-AAACGGCTACCACATCCAAG-30 58 C
50-CGCTCCCAAGATCCAACTAC-30streptomycin and 4 mmol/L glutamine. Cell-transfections were
performed using Fugene HD transfection reagent (Roche, Basel,
Switzerland) according to the manufacturer’s instructions.
2.2. Plasmids
Human cells were transfected with pcDNA3 plasmids contain-
ing 5, 200 or 960 CTG triplets [11] or co-transfected with human
Tau 2/3 or 2D3 minigenes as described [13]. Tau 2/3 and 2D3
minigenes differ from the endogenous MAPT gene by a truncation
of intron 1–2: the sequence of the intron upstream the exon 2
was limited to the 878 nucleotides located in the 50 region before
exon 2 (instead of the 9388 nt) (Fig. 2A). The length of intron 2–
3 is identical to MAPT gene in Tau 2/3 minigene whereas the 30 in-
tron 2–3 region is shorter in the Tau 2D3 minigene (2092nt instead
of 2439 nt in MAPT gene) (Fig. 2A).
Plasmids containing the 30UTR of DMPK with 5 or 200 CTG re-
peats were derived from previously described constructs under a
rodent ROSA promoter [14]. Brieﬂy, the plasmids contained 5 or
200 CTG triplets ﬂanked by the 30UTR sequences neighboring
(about 800 and 600 bp upstream and downstream) the CTG triplets.
The constructs were subcloned into pcDNA 3.1 under the control of
the CMV promoter [11]. The plasmid containing the 30UTR of DMPK
with 960 interrupted CTGs was aminigene construct also under the
control of the CMV promoter. It contained the last 5 exons of DMPK
followed by the full length DMPK 30UTR, with 960 CTG repeats
interrupted at every 20th repeat by CTCGA motif [15].
Plasmids DNA were puriﬁed using Nucleobond AX (Macherey-
Nagel).
2.3. Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was extracted from cells 48 h post-transfection using
a total RNA extraction kit (Nucleospin RNA II- Macherey-Nagel).
Total RNA (1.5 lg) was reverse transcribed using pd(N)6 random
hexamer (Amersham 27-2166-01) and Superscript First strand
synthesis system for RT-PCR, according to the supplier’s instruc-
tions (Invitrogen). After reverse transcription, the reaction mixture
was diluted four times. Five microliters of the diluted cDNAs were
ampliﬁed using Platinium PCR super mix (Invitrogen, California,
USA). Brieﬂy, the PCR mixture was heated at 94 C for 3 min and
followed by 25–35 cycles with 30 s at 94 C, 30–60 s at the correct
annealing temperature, depending on the primer pair used (see Ta-
ble 1), 1 min extension at 72 C and a ﬁnal extension step at 72 C
for 7 min. RT-PCR products were analyzed by 3% (wt/vol) agarose
gel electrophoresis and stained with ethidium bromide. RT-PCR
experiment was at least performed three times with total RNA ex-
tracted from three different passages of cell culture. 18S mRNA
ampliﬁcation was used as a control of RNA quantity [9]. Quantiﬁ-
cation of ethidium bromide luminescence was measured using aof Tau exons 2 and 3. The ﬁrst column indicates the sequences that were ampliﬁed
sense). PCR conditions and size of the fragments are indicated in the last two columns.
onditions: T Hybridization, cycle number Fragment size (bp)
, 35 cycles 933, 1020, 1026, 1107, 1113, 1200
, 35 cycles 112, 199, 286
, 25 cycles 290, 380, 470
, 25 cycles 290, 380
, 35 cycles 580, 487
, 15 cycles 250
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MultiGauge software (Fujiﬁlm). Statistic analyses of a minimum
of three individual experiments were calculated using Prism Soft-
ware and a Mann–Whitney U-Test.
3. Results
Several human cell lines were analyzed in order to identify two
distinct splicing patterns of Tau: one corresponding to the adult
pattern and the second corresponding to the foetal proﬁle of Tau
splicing. The endogenous Tau splicing pattern was analyzed in ner-
vous system derived human cells lines T98 and SY5Y cells. Using
the Tau E1/E13 primer pair (Table 1), we observed four bands in
T98 cell RNAs with a size corresponding to the four expected
bands, if all 6 adult isoforms of Tau are expressed (1200 bp,
±1100 bp, ±1000 bp, and 933 bp) (Fig. 1A). These bands were
cloned and sequenced to conﬁrm the identity of the isoforms of
Tau (not shown). In SY5Y cells, a major band corresponding to
the foetal isoform of Tau, without exons 2, 3 and 10, was mainly
observed. A minor band, corresponding to the isoform of Tau with
only one exon (exon 2 or 10), was also faintly detected. RT-PCR
analysis with Tau E2/E3 primers conﬁrmed that exon 2 of Tau
was preferentially included in T98 cells and excluded in SY5Y cells
(Fig. 1B). Using Tau E9/E13 primer pair to analyze the splicing of
exon 10, we detected a higher inclusion of exon 10 in T98
(33.2 ± 6.5%) than in SY5Y (17.9 ± 3.8%) cells (Fig. 1C and E). Thus,
sequencing of the bands ampliﬁed with Tau E1/E13 primer pair
as well as the separated analysis of exons 2/3 (Tau E1/E4 primerA
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Fig. 2. Structure of the human MAPT gene and minigenes. (A) Schematic representati
constitutive ones in black squares, the alternatively spliced ones in grey and the exon 8
scale of theMAPT exons and introns is artiﬁcial.MAPT gene is constituted of 16 exons amo
in the human central nervous system. In order to compare theMAPT sequence to that of T
surrounding introns. (B) Schematic representation of Tau minigenes: Tau 2/3 and Tau 2D
represented with white squares and bold lines. The length of the intronic sequences sur
Splicing of Tau 2/3 and Tau 2D3 minigenes in T98 and SY5Y cell lines. Identity of the banpair) and 10 (Tau E9/E13 primer pair) are in favour of a splicing
pattern of Tau in T98 cells similar to an adult brain pattern,
whereas in SY5Y, Tau splicing pattern is similar to a foetal one,
as quantiﬁed on Fig. 1E.
In order to determine whether the RNA cis-regulating element
required to reproduce the foetal pattern of Tau splicing is similar
or distinct from the one implicated in the trans-dominant effect
of CUG repeats, we used Tau minigenes (Fig. 2B). T98 and SY5Y
cells were transfected with minigenes Tau 2/3 or Tau 2D3 alone.
The dominant pattern was the inclusion of Tau exon 2 in both cell
lines (Fig. 2C). In T98 cells, the splicing pattern of Tau minigenes is
comparable to the endogenous one. In sharp contrast, we observed
an alternative splicing of Tau exons 2 or 2/3 from minigenes in
SY5Y cells. Indeed, Tau exon 2 is mainly included in SY5Y using
Tau 2/3 and Tau 2D3 minigenes (Fig. 2C: 12.2 ± 0.4% and
32.2 ± 3.0% of Tau exon 2 exclusion, respectively) that is strikingly
different from endogenous repression of Tau exon 2 inclusion
(more than 90% exclusion). Therefore, the cis-regulating elements
of Tau minigenes are sufﬁcient to reproduce the adult pattern of
Tau splicing but intronic splicing silencers necessary to reproduce
the foetal splicing pattern of Tau are likely missing since the inclu-
sion of Tau 2 is not completely repressed in SY5Y. If the cis-regulat-
ing element for the trans-dominant effect of CUG repeats and
foetal pattern of exon 2 splicing is the same, then Tau minigenes
should not respond to CUG repeats. Therefore, we took advantage
of the differences between T98 and SY5Y cell lines to analyze the
effects of CUG repeats (n = 5, 200 or 960) on Tau exon 2 splicing
from both endogenous or minigene transcripts.2439 bp 3903 bp
141312111098
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duced a signiﬁcant increase of the exclusion of the endogenous
Tau exon 2 (from 26.1 ± 2.3% to 40 ± 5.2%, P < 0.01) in T98 cells.
Noticeably, 200 CTG moderately modiﬁed the inclusion of Tau
exon 2 when compared to the normal CTG allele bearing 5 CTG re-
peats (Fig. 3A). In SY5Y, endogenous exon 2 exclusion was not fur-
ther enhanced by CTG repeats, suggesting that the repression of
exon 2 inclusion was maximum in this cell line. In contrast, the
CTG 960 repeats induced a clear and signiﬁcantly increased exon
2 exclusion in both T98 and SY5Y when these cell lines were co-
transfected with Tau 2D3 or Tau 2/3 minigenes (Fig. 3B and C).
Noticeably, 200 CTG repeats lightly but signiﬁcantly modiﬁed the
exclusion of Tau exon 2 from 2D3 and 2/3 minigene transcripts
in SY5Y (Fig. 3B and C). Our results demonstrated that inclusionA T98
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Fig. 3. Effect of CUG repeats expression on the alternative splicing of exon 2 or exons 2
transfected with pcDNA3.1 empty vector or pcDNA containing 5, 200 or 960 CTG repeats
(C) Analysis of minigene splicing after co-transfection of the CTG plasmids with Tau 2D3
Minigene splicing was analyzed by RT-PCR using Ins1/Ins3 primers. CTG 960 repeats favo
quantiﬁed as detailed in materials and methods. The number underneath each lane ind
independent experiment). Signiﬁcant differences are indicated by asterisks: *, P < 0.05;of exon 2 in minigene transcripts could be repressed by long
CUG tracks in both cell lines, and contrast with the endogenous
splicing pattern of Tau. We also veriﬁed that 30UTR of DMPK con-
structs bearing the CTG repeats were overexpressed at the same le-
vel by performing a RT-PCR of the region just downstream the
repeats (data not shown). Altogether, our results obtained using
Tau minigenes show that the cis-regulating element(s) necessary
to produce the foetal Tau isoform are dispensable for the trans-
dominant effect of CUG repeats.
4. Discussion
In this study, the question addressed, as far as Tau splicing is
concerned, was to determine whether the modiﬁed splicing ofSY5Y
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/3 of Tau. (A) Analysis of endogenous Tau splicing in both T98 and SY5Y cell lines
as indicated above the lanes. PCR were performed using Tau E1/E4 primers. (B) and
or Tau 2/3 minigenes, respectively. The plasmids were transfected with a 1:1 ratio.
ured the exclusion of exon 2 from both minigenes in both cells. PCR products were
icates the percentage of Tau exon 2 exclusion (averaged ± S.E.M. for at least three
**, P < 0.01.
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ated mechanism. The congenital form of DM1, which is the most
severe expression of the disease, is certainly resulting from a defec-
tive development of several organs, including the brain. In the
adult form, the development is ‘‘normal” and the onset and sever-
ity of the disease depend upon the length of CUG repeats in RNAs
translated by the mutated DMPK gene. The dynamic instability and
mosaicism of the mutation should also be considered as important
promoting factors. Nevertheless, long CUG repeats induce a modi-
ﬁed splicing of Tau leading to the greatly increased expression of
the foetal isoform [10,11]. The defective splicing of Tau affects
the three adult cassettes consisting of exons 2, 3 and 10 [8,10–
11]. Herein, we focused on Tau exons 2 and 3 as we previously
showed that the modiﬁed splicing of those exons was reproduced
in presence of long CUG tracks [11].
Alternative splicing implies cis- (RNA) and trans-regulating
(proteins) elements. In regard to Tau, several repressing factors of
the inclusion of Tau exon 2 have been characterized, such as
ETR-3 and MBNL1 [9,11,16]. However, less is known about the
cis-regulating elements and more particularly about the intronic
cis-regulating sequences. The Tau exon 2 default pattern of splicing
is the inclusion [13]. Therefore, the skipping of this exon is probably
due to a trans-repressing factor that recognizes an intronic splicing
silencer element. Our results are in favour of such a hypothesis. In
SY5Y cells, the endogenous exon 2 and exon 3 are mainly excluded
whereas they are mainly included when using Tau minigenes. In
contrast, exon 2 and exon 3 were mainly included in endogenous
Tau transcripts of T98 cells. There is one weak exonic splicing silen-
cer in exon 2 and one intronic splicing silencer in the 30 region of
intron 2–3 [17]. As these two elements are present in both endoge-
nousMAPT and Tauminigenes, the difference of Tau splicing pattern
is likely not mediated via those regulatory elements. Another possi-
bility would be that an intronic repressing element, yet unidenti-
ﬁed, is present in the intron 1–2 sequence. The intron 1–2 is
shorter in the minigene than in MAPT. The missing sequence may
contain one or several intronic splicing silencers that are essential
to produce the foetal isoform of Tau expressed in SY5Y cells. In re-
gards to DM1 pathophysiology, if the modiﬁed splicing pattern of
Tau results from an adult to foetal reprogramming of the splicing
machinery, the intronic splicing silencer necessary to produce the
foetal Tau isoform in SY5Y may also be the one targeted by the
trans-dominant effect of CUG repeats. To determine whether those
sequences were also necessary to mediate the trans-dominant ef-
fect of CUG repeats, the minigenes Tau 2D3 and 2/3 were co-ex-
pressed with 5, 200 or 960 CTG repeats in both T98 and SY5Y.
Inclusion of the exon 2 of Tau from the minigenes was strongly re-
pressed by CTG 960 demonstrating that there is a cis-repressing ele-
ment in Tau minigenes. Moreover, this repressing sequence implies
an inducible mechanism that is not functional by default. Thus, the
repression of Tau exon 2 inclusion is only activated following trans-
fection of CTG 960 and not observed using minigenes alone. Our re-
sults demonstrate that the sequence targeted by the trans-splicing
effect of CTG repeats is necessarily located in theminigenes. A foetal
Tau isoform is expressed in SY5Y. However, Tauminigenes are lack-
ing the cis-regulating elements necessary to reproduce this foetal
splicing. In contrast, Tau minigenes have a cis-repressing element
sensitive to CTG repeats, which together suggest that the latter
splicing mechanism is a disease-associated mechanism. This mech-
anism is likely independent of the foetal splicing process, as far as
Tau exon 2/3 splicing is concerned.
In conclusion, our data strongly suggest that the mechanism
leading to a defective inclusion of exons 2 and 3 in DM1 is likely
different from the one taking place during development. Therefore,
we propose that the modiﬁed splicing of Tau in DM1 may not bethe consequence of an adult to foetal reprogramming of the splic-
ing machinery. A disease-associated mechanism would be induced
by CUG repeats in mutated DMPK RNAs. Our results are important
in a therapeutic point of view since molecules that would restore
the normal splicing of Tau may not interfere with the mechanisms
implicated to generate the Tau adult isoforms. Our data strongly
suggest that both mechanisms are independent.
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